Dr. Raj K Gupta, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 31 N Locust St, West Carrollton, OH 45449 Phone: 937-898-7750 |
News Archive
Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA's Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) whose disease has progressed after at least one prior systemic therapy.
Addressing the American Legion's national convention, the president announced steps to expand access to mental health care and an initiative to lower home loan costs for military families. He also promised a new "culture of accountability' at the Department of Veterans Affairs.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
Dense Breast Notifications (DBNs) are having little impact. DBNs are a written notification to a woman after a mammogram that her breasts are dense. The goal is to motivate her speak with her doctor about her personal risk and possibly obtain supplemental screening for breast cancer.
› Verified 5 days ago